Dietmar Berger
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Gilead Sciences, Inc. (GILD)
Source not stated
Current -
Atara Biotherapeutics, Inc. (ATRA)
Proxy statement
Current -
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Current role
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Gilead Sciences, Inc. (GILD) | M.D., Ph.D. Chief Medical Officer | $969,231 | $13,922,878 |
| 2018 | Atara Biotherapeutics, Inc. (ATRA) | M.D., Ph.D. Former Global Head of Research & Development | $320,385 | $4,972,439 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.